跳至主要内容
临床试验/NL-OMON32766
NL-OMON32766已完成不适用

Improving practicality of radiofrequency ablation for eradication of Barrett*s mucosa: a randomized trial comparing two different treatment regimens for circumferential ablation using the HALO360 System - Radiofrequency ablation with HALO360 system: improvement treatment regiment

Academisch Medisch Centrum0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Scheduled HALO360 ablation for BE with flat low-grade dysplasia (LGD) or high-grade dysplasia (HGD) or for BE (with or without neoplasia) after prior endoscopic resection (ER) for lesions containing HGD or and early cancer.
  • - Review of histopathology specimens by a local expert pathologist
  • - Written informed consent

排除标准

  • - In case of prior Endoscopic resection: a specimen showing carcinoma with positive vertical resection margins, deep submucosal invasion (* T1sm2), poorly or undifferentiated cancer (G3 or G4), or lymphatic/vascular invasion.
  • - Patients unable to give informed consent.

研究者

相似试验